4Basebio
Heidelberg
About 4Basebio
4Basebio focuses on life science technology, DNA manufacturing, and supply DNA products to serve the fast-growing gene therapy market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $89.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: etr:4BSB
- Website: 4basebio.com
- Phone: 34 91 192 36 50
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Canonical: https://fsome.com/organization/4basebio-136546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.